Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico
Clinical trials sponsored by Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico, explained in plain language.
-
New drug duo targets recurrent skin cancer
Disease control TerminatedThis study aimed to test whether combining two existing cancer drugs (pembrolizumab and lenvatinib) could help control classic Kaposi sarcoma in people whose disease returned or didn't respond to previous chemotherapy. The trial planned to enroll adults with measurable skin lesio…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Skin patch study aims to find better endometriosis treatment
Disease control OngoingThis study compares two different hormone skin patch treatments for women with endometriosis to see which one provides better patient satisfaction after 6 months. Researchers are looking at how well each treatment controls pain and improves quality of life. The study involves 138…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Massive hospital study probes hidden kidney injury crisis
Knowledge-focused OngoingThis study aims to understand how common sudden kidney injury is in hospitalized patients and what happens to them after. Researchers will look back at the medical records of 43,000 patients admitted between 2019 and 2023. The goal is to gather information on how often this occur…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Apr 02, 2026 15:03 UTC